163 related articles for article (PubMed ID: 31867454)
1. Hemocompatibility and safety of the Carmat Total Artifical Heart hybrid membrane.
Richez U; De Castilla H; Guerin CL; Gendron N; Luraghi G; Grimme M; Wu W; Taverna M; Jansen P; Latremouille C; Migliavacca F; Dubini G; Capel A; Carpentier A; Smadja DM
Heliyon; 2019 Dec; 5(12):e02914. PubMed ID: 31867454
[TBL] [Abstract][Full Text] [Related]
2. Bioprosthetic Total Artificial Heart in Autoregulated Mode Is Biologically Hemocompatible: Insights for Multimers of von Willebrand Factor.
Poitier B; Chocron R; Peronino C; Philippe A; Pya Y; Rivet N; Richez U; Bekbossynova M; Gendron N; Grimmé M; Bories MC; Brichet J; Capel A; Rancic J; Vedie B; Roussel JC; Jannot AS; Jansen P; Carpentier A; Ivak P; Latremouille C; Netuka I; Smadja DM
Arterioscler Thromb Vasc Biol; 2022 Apr; 42(4):470-480. PubMed ID: 35139659
[TBL] [Abstract][Full Text] [Related]
3. The Carmat Bioprosthetic Total Artificial Heart Is Associated With Early Hemostatic Recovery and no Acquired von Willebrand Syndrome in Calves.
Smadja DM; Susen S; Rauch A; Cholley B; Latrémouille C; Duveau D; Zilberstein L; Méléard D; Boughenou MF; Belle EV; Gaussem P; Capel A; Jansen P; Carpentier A
J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1595-1602. PubMed ID: 28648774
[TBL] [Abstract][Full Text] [Related]
4. A bioprosthetic total artificial heart for end-stage heart failure: Results from a pilot study.
Latrémouille C; Carpentier A; Leprince P; Roussel JC; Cholley B; Boissier E; Epailly E; Capel A; Jansen P; Smadja DM
J Heart Lung Transplant; 2018 Jan; 37(1):33-37. PubMed ID: 28986001
[TBL] [Abstract][Full Text] [Related]
5. Elevated Circulating Stem Cells Level is Observed One Month After Implantation of Carmat Bioprosthetic Total Artificial Heart.
Guyonnet L; Detriché G; Gendron N; Philippe A; Latremouille C; Soret L; Capel A; Peronino C; Jansen P; Ivak P; Carpentier A; Mirault T; Netuka I; Guerin CL; Smadja DM
Stem Cell Rev Rep; 2021 Dec; 17(6):2332-2337. PubMed ID: 34622384
[TBL] [Abstract][Full Text] [Related]
6. First clinical use of a bioprosthetic total artificial heart: report of two cases.
Carpentier A; Latrémouille C; Cholley B; Smadja DM; Roussel JC; Boissier E; Trochu JN; Gueffet JP; Treillot M; Bizouarn P; Méléard D; Boughenou MF; Ponzio O; Grimmé M; Capel A; Jansen P; Hagège A; Desnos M; Fabiani JN; Duveau D
Lancet; 2015 Oct; 386(10003):1556-63. PubMed ID: 26231456
[TBL] [Abstract][Full Text] [Related]
7. Animal studies with the Carmat bioprosthetic total artificial heart.
Latrémouille C; Duveau D; Cholley B; Zilberstein L; Belbis G; Boughenou MF; Meleard D; Bruneval P; Adam C; Neuschwander A; Perles JC; Jansen P; Carpentier A
Eur J Cardiothorac Surg; 2015 May; 47(5):e172-8; discussion e178-9. PubMed ID: 25719178
[TBL] [Abstract][Full Text] [Related]
8. Numerical Approach to Study the Behavior of an Artificial Ventricle: Fluid-Structure Interaction Followed By Fluid Dynamics With Moving Boundaries.
Luraghi G; Wu W; De Castilla H; Rodriguez Matas JF; Dubini G; Dubuis P; Grimmé M; Migliavacca F
Artif Organs; 2018 Oct; 42(10):E315-E324. PubMed ID: 30298937
[TBL] [Abstract][Full Text] [Related]
9. In vitro haemocompatibility of a novel bioprosthetic total artificial heart.
Jansen P; van Oeveren W; Capel A; Carpentier A
Eur J Cardiothorac Surg; 2012 Jun; 41(6):e166-72. PubMed ID: 22491668
[TBL] [Abstract][Full Text] [Related]
10. Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.
Bartoli CR; Restle DJ; Zhang DM; Acker MA; Atluri P
J Thorac Cardiovasc Surg; 2015 Jan; 149(1):281-9. PubMed ID: 25439775
[TBL] [Abstract][Full Text] [Related]
11. In vitro comparison of the hemocompatibility of two centrifugal left ventricular assist devices.
Zayat R; Moza A; Grottke O; Grzanna T; Fechter T; Motomura T; Schmidt-Mewes C; Breuer T; Autschbach R; Rossaint R; Goetzenich A; Bleilevens C
J Thorac Cardiovasc Surg; 2019 Feb; 157(2):591-599.e4. PubMed ID: 30414772
[TBL] [Abstract][Full Text] [Related]
12. Total artificial heart implantation as a bridge to transplantation: a viable model for the future?
Beaupré RA; Frazier OH; Morgan JA
Expert Rev Med Devices; 2018 Oct; 15(10):701-706. PubMed ID: 30221561
[TBL] [Abstract][Full Text] [Related]
13. Hybrid membranes for the production of blood contacting surfaces: physicochemical, structural and biomechanical characterization.
Todesco M; Zardin C; Iop L; Palmosi T; Capaldo P; Romanato F; Gerosa G; Bagno A
Biomater Res; 2021 Aug; 25(1):26. PubMed ID: 34376256
[TBL] [Abstract][Full Text] [Related]
14. Autoregulation of Pulsatile Bioprosthetic Total Artificial Heart is Involved in Endothelial Homeostasis Preservation.
Smadja DM; Chocron R; Rossi E; Poitier B; Pya Y; Bekbossynova M; Peronino C; Rancic J; Roussel JC; Kindo M; Gendron N; Migliozzi L; Capel A; Perles JC; Gaussem P; Ivak P; Jansen P; Girard C; Carpentier A; Latremouille C; Guerin C; Netuka I
Thromb Haemost; 2020 Sep; 120(9):1313-1322. PubMed ID: 32688422
[TBL] [Abstract][Full Text] [Related]
15. Current Role of the Total Artificial Heart in the Management of Advanced Heart Failure.
Melton N; Soleimani B; Dowling R
Curr Cardiol Rep; 2019 Nov; 21(11):142. PubMed ID: 31758343
[TBL] [Abstract][Full Text] [Related]
16. Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart.
Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Benk C; Berchtold-Herz M; Trummer G; Schlensak C; Zieger B
Thromb Haemost; 2010 May; 103(5):962-7. PubMed ID: 20352153
[TBL] [Abstract][Full Text] [Related]
17. Blood damage in Left Ventricular Assist Devices: Pump thrombosis or system thrombosis?
Selmi M; Chiu WC; Chivukula VK; Melisurgo G; Beckman JA; Mahr C; Aliseda A; Votta E; Redaelli A; Slepian MJ; Bluestein D; Pappalardo F; Consolo F
Int J Artif Organs; 2019 Mar; 42(3):113-124. PubMed ID: 30354870
[TBL] [Abstract][Full Text] [Related]
18. The Biocompatibility Challenges in the Total Artificial Heart Evolution.
Dal Sasso E; Bagno A; Scuri STG; Gerosa G; Iop L
Annu Rev Biomed Eng; 2019 Jun; 21():85-110. PubMed ID: 30795701
[TBL] [Abstract][Full Text] [Related]
19. Persistent anemia after implantation of the total artificial heart.
Mankad AK; Tang DG; Clark WB; Flattery M; Harton S; Katlaps GJ; Stribling WK; Cooke RH; Hess ML; Kasirajan V; Shah KB
J Card Fail; 2012 Jun; 18(6):433-8. PubMed ID: 22633300
[TBL] [Abstract][Full Text] [Related]
20. Design and Hemocompatibility Analysis of a Double-Suction Injection Suspension Blood Pump Using Computational Fluid Dynamics Methods.
Wu Y; Zhu L; Luo Y
Artif Organs; 2017 Nov; 41(11):979-987. PubMed ID: 28744907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
